(0.09%) 5 474.14 points
(0.10%) 39 152 points
(0.41%) 17 790 points
(-0.22%) $80.65
(-3.66%) $2.66
(-0.77%) $2 312.80
(0.20%) $28.93
(3.49%) $1 020.80
(0.28%) $0.936
(0.70%) $10.68
(0.46%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases...
Stats | |
---|---|
今日成交量 | 20 257 |
平均成交量 | 98 925 |
市值 | 415.58M |
EPS | $-10.50 ( Q1 | 2024-03-31 ) |
下一个收益日期 | ( $-0.810 ) 2024-08-15 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.285 (1.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-09 | English Emily | Sell | 0 | Common Stock |
2024-04-09 | English Emily | Sell | 14 254 | Stock Option (Right to Buy) |
2024-04-09 | English Emily | Sell | 23 433 | Stock Option (Right to Buy) |
2024-04-08 | Singer Michael | Buy | 377 208 | Common Stock |
2024-04-08 | Singer Michael | Buy | 110 151 | Common Stock |
INSIDER POWER |
---|
75.69 |
Last 44 transactions |
Buy: 16 103 370 | Sell: 2 254 554 |
音量 相关性
Cartesian Therapeutics, 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Cartesian Therapeutics, 相关性 - 货币/商品
Cartesian Therapeutics, 财务报表
Annual | 2023 |
营收: | $26.00M |
毛利润: | $24.45M (94.03 %) |
EPS: | $-42.58 |
FY | 2023 |
营收: | $26.00M |
毛利润: | $24.45M (94.03 %) |
EPS: | $-42.58 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cartesian Therapeutics,
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company\'s lead therapeutic gene therapy program is SEL-302 that is in Phase I clinical trial to enhance the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therapies comprising for the treatment of pompe disease, duchenne muscular dystrophy, limb-girdle muscular dystrophy, lysosomal storage disorder, and other autoimmune diseases. Further, it develops tolerogenic therapies to treat autoimmune diseases. The company has license and collaboration agreements with Ginkgo Bioworks Holdings, Inc.; Genovis AB (publ.); Cyrus Biotechnology, Inc.; IGAN Biosciences, Inc.; Astellas Therapeutics, Inc.; Takeda Pharmaceuticals USA, Inc.; Swedish Orphan Biovitrum AB (publ.); Sarepta Therapeutics, Inc.; Asklepios Biopharmaceutical, Inc.; Massachusetts Institute of Technology; and Shenyang Sunshine Pharmaceutical Co., Ltd. Selecta Biosciences, Inc. was incorporated in 2007 and is headquartered in Watertown, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。